Dihydrotestosterone (DHT)

For research use only. Not for use in humans.

目录号:S4757 别名: androstanolone, stanolone, 5α-DHT 中文名称:双氢睾酮

Dihydrotestosterone (DHT) Chemical Structure

CAS No. 521-18-6

Dihydrotestosterone (DHT, androstanolone, stanolone, 5α-DHT)是一种内源性的雄激素性类固醇和激素,是雄激素受体的激动剂,其亲和力比睾酮高2-3倍,诱导雄激素受体信号的效力比睾酮高3倍。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 1367.81 现货
RMB 1286.81 现货
RMB 3030.86 现货
有超大折扣
今日订购,明日送达 全国免运费 分装免费
全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Dihydrotestosterone (DHT)发表文献14篇:

产品安全说明书

Androgen Receptor抑制剂选择性比较

生物活性

产品描述 Dihydrotestosterone (DHT, androstanolone, stanolone, 5α-DHT)是一种内源性的雄激素性类固醇和激素,是雄激素受体的激动剂,其亲和力比睾酮高2-3倍,诱导雄激素受体信号的效力比睾酮高3倍。
靶点
Androgen Receptor [1]
()
体外研究

在雄激素受体阳性的膀胱癌UMUC3和TCC-SUP细胞中,dihydrotestosterone (DHT)可在mRNA和蛋白水平上增加EGFR和ERBB2的表达。在AR阳性细胞中,DHT还可上调EGFR磷酸化水平及其下游蛋白AKT(pAKT)和ERK1/2(pERK)的磷酸化水平[1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CV-1 cell MYTGeY5kfGmxbjDhd5NigQ>? NHTy[mdC\2:waYP0bYMh[WO2aY\peJkhMEWFNUCpJIFo[Wmwc4SgbJVu[W5iYX7kdo9o\W5icnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGNXNTFiY3XscEwhTUN3ME2wMlAxPiEQvF2= MnvDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwQTh5MUWzOEc,QTh5MUWzOFww[T5?
MDA-MB-453 cell NW[2bIVuTnWwY4Tpc44h[XO|YYm= NILw[ZRFcXOybHHj[Y1mdnRib3[gX|NJZUSKVDDmdo9uKGi3bXHuJIFv\HKxZ3XuJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCPRFGtUWIuPDV|IHPlcIx{KGK7IIfoc4xmKGOnbHygdoVk\XC2b4KgZolv\GmwZzDhd5NigSxiS3m9NE4xODB{IN88US=> MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzB|NEGxO{c,OTdyM{SxNVc9N2F-
HepG2 cell MlvlSpVv[3Srb36gZZN{[Xl? NWTQV2JqSWO2aY\peJkh[WejaX7zeEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYYPz[ZN{\WRiYYOgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHjeIl3[XSrb36sJGlEPTB;MD6wNVgzKM7:TR?= NYDjRXVWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUexOFk5PjZpPkG3NVQ6QDZ4PD;hQi=>
MDA453 cell M1XWXmZ2dmO2aX;uJIF{e2G7 NVrwZmRZTGm|cHzhZ4Vu\W62IH;mJHs{UF2GSGSg[pJwdSCqdX3hckBCWiCrbjDNSGE1PTNiY3XscJMtKEurPUCuNFA{KM7:TR?= NYLifnFuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUexPFEyPDFpPkG3NVgyOTRzPD;hQi=>
mouse C2C12 cell NWTscFB2TnWwY4Tpc44h[XO|YYm= NGjnXohC\2:waYP0JIFkfGm4aYT5JIF1KHKjdDDBVkB1emGwc3\lZ5Rm\CCrbjDtc5V{\SCFMlOxNkBk\WyuczDifUBtfWOrZnXyZZNmKHKncH;yeIVzKHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCyPEDPxE1? M3y5T|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MUixNVQyLz5zN{G4NVE1OTxxYU6=
monkey COS7 cell M33GTGZ2dmO2aX;uJIF{e2G7 NWGxNXpKSmmwZHnu[{Bi\m[rbnn0fUB1dyCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5ibX;ub4V6KEORU{egZ4VtdHNiYomge4hwdGViY3XscEBjcW6maX7nJIF{e2G7LDDLbV0xNjByMEKg{txO NVS3fVNFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OFI6OTJpPkG4OFQzQTF{PD;hQi=>
CHO cell MYTGeY5kfGmxbjDhd5NigQ>? MnPURYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDUS3I2KGW6cILld5Nm\CCrbjDDTG8h[2WubIOgZpkhdHWlaX\ldoF{\SCjc4PhfUwhTUN3ME20MlQ6KM7:TR?= NV3z[GdURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUizNFczQTRpPkG4N|A4Ojl2PD;hQi=>
COS7 cell MWfGeY5kfGmxbjDhd5NigQ>? MkXBRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDXO|QySyCvdYThcpQh\XiycnXzd4VlKGmwIFPPV|ch[2WubIOgZZN{\XO|ZXSgZZMhdHWlaX\ldoF{\SCjY4Tpeol1gSCjZoTldkAzPCCqcoOgZpkhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjBzMjFOwG0> NFS0THo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC5OFI4QSd-MkKwPVQzPzl:L3G+
COS7 cell MWDGeY5kfGmxbjDhd5NigQ>? NULnPGtrSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBVQDd5QTDteZRidnRiZYjwdoV{e2WmIHnuJGNQWzdiY3XscJMh[XO|ZYPz[YQh[XNibIXjbYZmemG|ZTDhZ5Rqfmm2eTDh[pRmeiB{NDDodpMh[nlicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCxOUDPxE1? M1\GTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEm0Nlc6Lz5{MkC5OFI4QTxxYU6=
COS7 cell NXfScHBjTnWwY4Tpc44h[XO|YYm= MmnKRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hS0:VNzDj[YxteyCjc4Pld5Nm\CCjczDseYNq\mW{YYPlJIFkfGm4aYT5JIFnfGW{IEK0JIhzeyCkeTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFA3OiEQvF2= M1:w[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEm0Nlc6Lz5{MkC5OFI4QTxxYU6=
LNCaP-hr cell MUfGeY5kfGmxbjDhd5NigQ>? Mn;2N{Bl[Xm| M1XjSmFod26rc4SgZYN1cX[rdImgZZQhSW6mcn;n[Y4hemWlZYD0c5IhXDh5N1GgcZV1[W62IHnuJIh2dWGwIFzOR4FRNWi{IHPlcIx{KGG|c3Xzd4VlKGG|IIDyc5N1[XSnIIPw[YNq\mmlIHHueIlo\W5ic3XjdoV1cW:wIH3lZZN2emWmIHHmeIVzKDNiZHH5d{BjgSCnbor5cYUucW2vdX7vZZN{[XluIFXDOVA:OC5yMUWg{txO NUf3RphJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxPVk1PzdpPkKzNVk6PDd5PD;hQi=>
LNCaP-hr cell NWDYZWVqTnWwY4Tpc44h[XO|YYm= MojYN{Bl[Xm| M4XUSWFod26rc4SgZYN1cX[rdImgZZQhf2muZDD0fZBmKEGwZILv[4VvKHKnY3XweI9zKGmwIHj1cYFvKEyQQ3HQMYhzKGOnbHzzJIF{e2W|c3XkJIF{KHC{b4P0ZZRmKHOyZXPp[olkKGGwdHnn[Y4he2WlcnX0bY9vKG2nYYP1doVlKGGodHXyJFMh\GG7czDifUBmdnq7bXWtbY1ufW6xYYPzZZktKEWFNUC9NE4xODZ{IN88US=> M3\CcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUm5OFc4Lz5{M{G5PVQ4PzxxYU6=
HEK293 cell M3W4PGZ2dmO2aX;uJIF{e2G7 Mlj5RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjF6IH7N NHnI[GE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUOwOVY5QCd-MkWzNFU3QDh:L3G+
COS NVrGSIRuTnWwY4Tpc44h[XO|YYm= Mne4Rolv\GmwZzDh[oZqdmm2eTDh[4FqdnO2IFHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDDU3Mh[2WubIOsJGtqKD1iMD6wNFIh|ryPLh?= NE\VV4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi97OEexOVM1Lz57OEexOVM1RC:jPh?=
COS-1 M2SxV2Z2dmO2aX;uJIF{e2G7 MlPYRolv\GmwZzDh[oZqdmm2eTDmc5IhcHWvYX6gRY5lem:pZX6gdoVk\XC2b4Kg[ZhxemW|c3XkJIlvKEORUz2xJINmdGy|LDDLbUA:KDBwMECzJO69VS5? MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek86QTJ3N{K1K|46QTJ3N{K1QE9iRg>?
CV-1 MVTGeY5kfGmxbjDhd5NigQ>? NWDn[XpMSWexbnnzeEBi[3Srdnn0fUBi\2GrboP0JGh2dWGwIFHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBEXi1zIHPlcIx{NCCHQ{WwJF0hOC5yMEWg{txONg>? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek86QTJ3N{K1K|46QTJ3N{K1QE9iRg>?
COS NIXyPGZHfW6ldHnvckBie3OjeR?= NG\CRo5KdiC4aYTyc{BjcW6maX7nJIFn\mmwaYT5JIF1KGi3bXHuJIFv\HKxZ3XuJJJm[2WydH;yJJRz[W6|ZnXjeIVlKGmwdH:gR29UKGOnbHzzMkwhUUN3MDC9JFAvODB2IN88UU4> MnXGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB{M{C2NlgoRjFyMkOwOlI5RC:jPh?=
CV-1 NWnGe4ZwTnWwY4Tpc44h[XO|YYm= Mm\NTY4hfmm2cn:gZYdwdmm|dHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iYX7kdo9o\W5icnXj[ZB1d3JidYPpcoch[2:2cnHud4Zm[3Srb36gZZN{[XliaX6gR3YuOSClZXzsd{4tKEWFNUCgQUAxNjByNjFOwG0v Mo\TQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB{M{C2NlgoRjFyMkOwOlI5RC:jPh?=
CV-1 Ml2xSpVv[3Srb36gZZN{[Xl? NGPldVJC\2:waYP0JIFkfGm4aYT5JJRwKHSqZTDoeY1idiCjbnTyc4dmdiC{ZXPldJRweiBqaFHSLUBqdiCFVj2xJINmdGy|LDDFR|UxKD1iMD6wNFYh|ryPLh?= M{jjTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFyM{SwOlI1Lz5zMEO0NFYzPDxxYU6=
CV1 MoPUSpVv[3Srb36gZZN{[Xl? MnPDRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDpckBEXjFiY3XscJMhdWWjc4Xy[YQh[XNic4TpcZVt[XSrb36gc4YhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIFkfGm4aYT5JIJ6KGOxdILhcpNn\WO2aX;uJIF{e2G7LDDFR|UxKD1iMD6wNFUyKM7:TT6= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzB|NEGxO{c,OTdyM{SxNVc9N2F-
CV1 NInERpNHfW6ldHnvckBie3OjeR?= NWHTcHM5SmmwZHnu[{Bi\m[rbnn0fUB1dyCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5iQ2[xJINmdGy|LDDLbUA:KDBwMECwNkDPxE1w M{XCT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MkW3PFM5Lz5zN{K1O|g{QDxxYU6=
CV1 MoS5SpVv[3Srb36gZZN{[Xl? NHq5SmFC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJIFv\HKxZ3XuJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCFVkGgZ4VtdHNuIFXDOVAhRSByLkCwOVEh|ryPLh?= NU\DeVRFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUeyOVc5OzhpPkG3NlU4QDN6PD;hQi=>
MDA-MB-453 MYjGeY5kfGmxbjDhd5NigQ>? MWnEbZNxdGGlZX3lcpQhd2ZiW{PIYWRJXCCocn;tJIh2dWGwIFHSJIV5eHKnc4Pl[EBqdiCPRFGtUWIuPDV|IHPlcIx{NCCNaTC9JFAvODByMzFOwG0v MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzR|OUGxNkc,OTd2M{mxNVI9N2F-
CV1 MoGxSpVv[3Srb36gZZN{[Xl? MnXWRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hS1ZzIHPlcIx{KGK7IITyZY5{[3KrcITpc45idCCjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwJF0hOC5yMEW3JO69VS5? NWLDelVjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe0N|kyOTJpPkG3OFM6OTF{PD;hQi=>
CV1 NVvjXYgxTnWwY4Tpc44h[XO|YYm= NWPQZ5FNSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5iQ2[xJINmdGy|IHL5JJRz[W6|Y4LpdJRqd26jbDDhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxKD1iMD6wNFU4KM7:TT6= NGP4N5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{ewN|k{QCd-MUe3NFM6Ozh:L3G+
MDA-MB-453 Ml\WSpVv[3Srb36gZZN{[Xl? NHnSXXdFcXOybHHj[Y1mdnRib3[gX|NJZUSKVDDmdo9uKGi3bXHuJGFv\HKxZ3XuJJJm[2WydH;yJIlvKGi3bXHuJG1FSS2PQj20OVMh[2WubIOsJGtqKD1iMD6wNFA6KM7:TT6= M3fxS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NECwOFk6Lz5zOESwNFQ6QTxxYU6=
CV1 NWrROWwyTnWwY4Tpc44h[XO|YYm= MnvtRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDpckBEXjFiY3XscJMh[nlidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYYPzZZktKEWFNUCgQUAxNjByNUeg{txONg>? M3TK[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NECwOFk6Lz5zOESwNFQ6QTxxYU6=
Saos2 NXfOVHpQTnWwY4Tpc44h[XO|YYm= MUjBZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBqdiCqdX3hckBU[W:|MjDj[YxteyCjc4Pld5Nm\CCjczDJUFYhemWycnXzd4lwdixiSVO1NEA:KDBwMECwNFUh|ryPLh?= NXnOTXE5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OFI6OTJpPkG4OFQzQTF{PD;hQi=>
CV1 NIPtVVRHfW6ldHnvckBie3OjeR?= NXnZeFQ3SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBi\nKrY3HuJIdz\WWwIH3vcotmgSCFVkGgZ4VtdHNiYomgZ491emGwc3\lZ5Rqd25iYYPzZZktKEWFNUCgQUAxNjByNUGg{txONg>? M1;uUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NESyPVEzLz5zOES0NlkyOjxxYU6=
MDA-kb2 MlvkSpVv[3Srb36gZZN{[Xl? MnTPRYdwdmm|dDDhZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBqdiCqdX3hckBOTEFva3KyJINmdGy|IHHzd4V{e2WmIHHzJJN1cW23bHH0bY9vKG:oIHz1Z4ln\XKjc3WgZYN1cX[rdImgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|E2OCB;IECuNFAxPSEQvF2u M32wPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NUmyNlQ2Lz5zOUW5NlI1PTxxYU6=
MDA-kb2 MnnWSpVv[3Srb36gZZN{[Xl? MW\B[49vcXO2IHHjeIl3cXS7IHH0JIdtfWOxY3;yeIlkd2mmIILlZ4VxfG:{IHnuJIh2dWGwIF3ERU1s[jJiY3XscJMh[XO|ZYPz[YQh[XNic4TpcZVt[XSrb36gc4YhdHWlaX\ldoF{\SCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFMUWwJF0hOC5yMEC1JO69VS5? Mn[5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl3OUKyOFUoRjF7NUmyNlQ2RC:jPh?=
MDA-MB-453 NFv1TZJHfW6ldHnvckBie3OjeR?= M{jsUGRqe3CuYXPlcYVvfCCxZjDbN2hedWW2aInseJJq\W6xbH;u[UBnem:vIHHu[JJw\2WwIILlZ4VxfG:{IHnuJIh2dWGwIF3ERU1OSi12NUOgZ4VtdHNuIFnDOVAhRSByLkCwNUDPxE1w NH\1[oE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[wOlg4OCd-MUm2NFY5PzB:L3G+
MDA-MB-453 M2HYOWZ2dmO2aX;uJIF{e2G7 M{e4UWFod26rc4SgZYN1cX[rdImgZZQh[W6mcn;n[Y4hemWlZYD0c5IhcW5iaIXtZY4hVUSDLV3CMVQ2OyClZXzsd{B1emGwc3\lZ5Rm\CC5aYToJG1OXFZvTGXDJIF{e2W|c3XkJIF{KGmwZIXjeIlwdiCxZjDNUXRXNUyWUj;wdo9ud3SncjDsbY5s\WRiTGXDJIdmdmViYomgcJVkcW[ncnHz[UB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVAhRSByLkCwNkDPxE1w NEDlO5o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[wOlg4OCd-MUm2NFY5PzB:L3G+
NIH3T3 MoDkSpVv[3Srb36gZZN{[Xl? MWjB[49vcXO2IHHjeIl3cXS7IHH0JIFv\HKxZ3XuJJJm[2WydH;yJGxDTCCWOEe3RUBufXSjboSgbY4hdW:3c3WgUmlJO1R|IHPlcIx{KHS{YX7zbYVvfGy7IITyZY5{\mWldHXkJJdqfGhiYnX0ZU1o[WyjY4Tvd4ll[XOnIILldI9zfGW{IHflcoUh[XO|ZYPz[YQh[XNiY3XscJVt[XJidILhcpNnd3KvYYTpc44h[nliUj3TRXQh[XO|YYmsJGVEPTBiPTCwMlAxOTJ3OTFOwG0v M2nyU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEW2PVIyLz5zOUi1OlkzOTxxYU6=
NIH3T3 Mnz5SpVv[3Srb36gZZN{[Xl? NHr3RmVC\2:waYP0JIFkfGm4aYT5JIF1KGGwZILv[4VvKHKnY3XweI9zKGmwIH3veZNmKE6LSEPUN{Bk\WyuczD0doFve2mnboTsfUB1emGwc3\lZ5Rm\CC5aYToJIJmfGFvZ3HsZYN1d3OrZHHz[UBz\XCxcoTldkBo\W6nIHHzd4V{e2WmIHHzJINmdGy3bHHyJJRz[W6|Zn;ycYF1cW:wIHL5JHIuW0GWIHHzd4F6NCCHQ{WwJF0hOC5yMEO5PFEh|ryPLh?= MmLhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6NU[5NlEoRjF7OEW2PVIyRC:jPh?=
COS7 M1O1U2Z2dmO2aX;uJIF{e2G7 MXLB[49vcXO2IHHjeIl3cXS7IHH0JIFv\HKxZ3XuJJJm[2WydH;yJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS0:VNzDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIFfhcFQuTEKGIHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NEA:KDBwMEKg{txONg>? NVP3VXM2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm4OlMxQDNpPkG5PFY{ODh|PD;hQi=>
Freestyle293F NHTpNW9HfW6ldHnvckBie3OjeR?= M3n1PVMhcHK| MlrjSIl{eGyjY3Xt[Y51KG:oIGuxO{1idHCqYT3t[ZRpgWxvM1jdMY1q[m:uZYLvcoUh\nKxbTDoeY1idiCjbnTyc4dmdiC{ZXPldJRweiCneIDy[ZN{\WRiaX6gTGVMOjl|IHTldol3\WRiRoLl[XN1gWynMkmzSkBk\WyuczDh[pRmeiB|IHjyd{whUUN3MDC9JFAvODB{MTFOwG0v MmTOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyOUSyO|koRjJ{MEm0Nlc6RC:jPh?=
Freestyle293F M2PzPGZ2dmO2aX;uJIF{e2G7 MkDqN{BpenN? NXyw[YkzTGm|cHzhZ4Vu\W62IH;mJHsyPy2jbIDoZU1u\XSqeXytN2heNW2rYn;s[ZJwdmViZoLvcUBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDUPFc4SSCvdYThcpQh\XiycnXzd4VlKGmwIFjFT|I6OyCmZYLpeoVlKE[{ZXXTeJlt\TJ7M1[gZ4VtdHNiYX\0[ZIhOyCqcoOsJGlEPTBiPTCwMlAxOjZizszNMi=> MlP5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyOUSyO|koRjJ{MEm0Nlc6RC:jPh?=
HeLa M2nLNWZ2dmO2aX;uJIF{e2G7 MVHUdoFve2GldHn2ZZRqd25ib3[gbJVu[W5iYX7kdo9o\W5icnXj[ZB1d3JidILhcpNn\WO2ZXSgbY4hcHWvYX6gTIVN[SClZXzsd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGFkfGm4aYT5JF0hOC5yMEig{txONg>? M1LNT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEm3OlEyLz5{Mki5O|YyOTxxYU6=
HeLa MWLGeY5kfGmxbjDhd5NigQ>? NUS3OldUWGG{dHnhcEBi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJIFv\HKxZ3XuJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCKZVzhJINmdGy|IHPvMYV5eHKnc4PpcochSVKHIHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDiZZNm\CC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGFkfGm4aYT5JF0hOC5yMEig{txONg>? NHzEUGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mkm1O|k1Pyd-MkK5OVc6PDd:L3G+
Freestyle293F NHTKNlNHfW6ldHnvckBie3OjeR?= NIrmUGVKdmirYnn0bY9vKG:oIIfpcIQhfHmyZTDBcoRzd2enbjDy[YNmeHSxcjCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBHemWnc4T5cIUzQTOIIHPlcIx{NCCLQ{WwJF0hOC5yMEKxJO69VS5? NVTic5l{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxPVk1PzdpPkKzNVk6PDd5PD;hQi=>
Freestyle293F NHPMcGtHfW6ldHnvckBie3OjeR?= MnTpTY5pcWKrdHnvckBw\iCDbnTyc4dmdiC{ZXPldJRweiCWOEe3RUBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hTnKnZYP0fYxmOjl|RjDj[YxteyxiSVO1NEA:KDBwMECyOkDPxE1w MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF7OUS3O{c,OjNzOUm0O|c9N2F-
COS7 NEjzWFBHfW6ldHnvckBie3OjeR?= NECyNpkzKGi{cx?= MV3EbZNxdGGlZX3lcpQhd2ZiW{PIYUBePWGucHjhMWRJXCCocn;tJI1wfXOnIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBud26tZYmgR29UPyClZXzsd{Bi\nSncjCyJIhzeyCkeTDzZ4lvfGmubHH0bY9vKGOxdX70bY5oKGGwYXz5d4l{NCCLQ{WwJF0hOC5yMEGg{txONg>? NWDJOJRPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1Nlc5OTZpPkKzOVI4QDF4PD;hQi=>
C2C12 NUH3b3dXTnWwY4Tpc44h[XO|YYm= NF3ZTpA2KGSjeYO= MkPwRYdwdmm|dDDhZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5ibX;1d4UhSzKFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOgc5N1\W:kbHHzeEBlcW[oZYLlcpRq[XSrb36gZYZ1\XJiNTDkZZl{NCCHQ{WwJF0hOC5yMECwOUDPxE1w NWXucGtrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzQTBpPkK0PVAxOjlyPD;hQi=>
C2C12 NH7GcFlHfW6ldHnvckBie3OjeR?= NV2xd2xZSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5ibX;1d4UhSzKFMUKgZ4VtdHNiYomgZY5lem:pZX6td5Bm[2moaXOgdoV{eG:wc3Wg[YxmdWWwdD3kdol3\W5ibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xODBzMzFOwG0v NFfOS489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUGyNVk3PCd-MkWxNlE6PjR:L3G+
COS7 M3PuN2Z2dmO2aX;uJIF{e2G7 MorzNlQhcHK| MVfB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFHSJIV5eHKnc4Pl[EBqdiCDZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3M4KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjByMzFOwG0v NEiwWpY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES1OFg1QSd-Mki0OVQ5PDl:L3G+
Shionogi NFezZ4pHfW6ldHnvckBie3OjeR?= M2f2flExKHCP MXLJcoR2[3Srb36gc4YheHKxbHnm[ZJifGmxbjDv[kBud3W|ZTDTbIlwdm:paTDj[YxteyCjdDCxNEBxVQ>? NGXFbHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{exNVg2PSd-MUe3NVE5PTV:L3G+
MCF7 NED2VlhHfW6ldHnvckBie3OjeR?= MkDGN|AhfU1? MmDrNlQhcHK| MX7BcpRi\2:waYP0JIFkfGm4aYT5JIF1KEGUIHnuJIh2dWGwIF3DSlch[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIFHSJIxmfmWuIHH0JFMxKHWPIHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm|aYOgdoVt[XSrdnWgeI8h[2:wdILvcC=> M3PI[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEG0O|UyLz5{MkCxOFc2OTxxYU6=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
Cyclin D1 / Cyclin D2 / Cyclin D3 / Cyclin E2 / Cyclin A1 / AR; 

PubMed: 26372468     


HPr-1AR cells were treated with 10 nM DHT or vehicle control for 24–48 hours (h), and immunoblot analysis of cell lysates reveals that cyclin D1 and D2 protein expression decreased substantially with DHT treatment compared to vehicle.

p-CDK2 / CDK2 / CDK4 / CDK6 / CDKN1A / p-RB / RB ; 

PubMed: 26372468     


HPr-1AR cells were treated with 10 nM DHT or vehicle control for 24–48 hours (h). Immunoblot analysis of cell lysates reveals that CDK4 and CDK6 protein expression decreased and CDKN1A expression increased with DHT treatment compared to vehicle. CDK2 phosphorylation at threonine 160 (T160) decreased nearly 50% with androgen treatment at 24 and 48 hours, albeit not significantly, and total CDK2 protein expression remained unchanged. Relative to total RB expression, the levels of various phosphorylated forms of RB (S780 and S807/811) decreased over time with androgen treatment. 

p27 / p-p27 ; 

PubMed: 22139837     


CWR22Rv1 or CWR22R3 cells were stimulated with 10 nm DHT for 6 h, with the addition of MG132 during the last 2 h before harvesting. Proteins were then immunoblotted.

AR / PP1 ; 

PubMed: 26636645     


HeLa cells were transfected with Flag-PP1α and HA-AR and then incubated for overnight in androgen-depleted medium without or with androgen (10 nM of DHT) as indicated for blotting. 

26372468 22139837 26636645
Immunofluorescence
FOXO1 / p27 ; 

PubMed: 22139837     


CWR22R3 cells cultured in medium with CDS serum were treated without/with DHT (10 nm) for 4 h. The cells were immunostained for FOXO1 and p27 and examined with a confocal microscope. 

AKT(S473) / PKCα(S657) ; 

PubMed: 22139837     


CWR22R3 cells cultured in medium with CDS serum were treated without/with 10 nm DHT (−/+ DHT) for 4 h. The cells were immunostained for AKT or PKCα phosphorylation and examined with a confocal microscope. Bars: 20 μm

22139837
体内研究 DHT可减轻SOD1-G93A小鼠的肌萎缩症状并增加其体重。DHT的处理增加了肌肉中胰岛素样生长因子1的表达,通过逆向轴浆运输发挥其肌肉营养性和神经营养性效果。其处理还减缓了神经肌肉接头处的去神经支配作用、以及减少轴突和运动神经元的丢失。DHT处理的SOD1-G93A小鼠改善了运动行为,生命期限也有所延长[2]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

细胞实验:

[1]

- 合并
  • Cell lines: 膀胱癌细胞
  • Concentrations: 1 nM
  • Incubation Time: 24 h
  • Method:

    对铺于24孔板的、达到50%-60%融合率的细胞进行MMTV-luc报告质粒和PRL-TK-luc质粒共转染实验。转染完6小时后,将培养基替换为含活性炭处理胎牛血清的培养基,加入或不加入配体(DHT、HF或同时加入),处理24小时。收集细胞、溶解、进行荧光素酶活性检测。


    (Only for Reference)
动物实验:

[2]

- 合并
  • Animal Models: SOD1-G93A mutant mice with the congenic C57BL/6J background
  • Dosages: 5 mg
  • Administration: silastic implant
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 58 mg/mL (199.69 mM)
Ethanol 58 mg/mL (199.69 mM)
Water Insoluble

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 290.44
化学式

C19H30O2

CAS号 521-18-6
储存条件 粉状
溶于溶剂
别名 androstanolone, stanolone, 5α-DHT

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05033444 Recruiting Drug: PRV-002|Drug: Placebo Traumatic Brain Injury (TBI) Odyssey Group International Inc.|Avance Clinical Pty Ltd. September 17 2021 Phase 1
NCT04989972 Not yet recruiting Drug: PSIL428|Dietary Supplement: Oyster mushroom Anxiety and Depression Wake Network Inc.|Professor Roger Gibson Section of Psychiatry Faculty of Medical Sciences UWI September 15 2021 Phase 2
NCT05042895 Recruiting Procedure: Group A|Procedure: Group B Infertility Woman''s Health University Hospital Egypt August 20 2021 Not Applicable

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

Androgen Receptor Signaling Pathway Map

相关Androgen Receptor产品

Tags: 购买Dihydrotestosterone (DHT) | Dihydrotestosterone (DHT)供应商 | 采购Dihydrotestosterone (DHT) | Dihydrotestosterone (DHT)价格 | Dihydrotestosterone (DHT)生产 | 订购Dihydrotestosterone (DHT) | Dihydrotestosterone (DHT)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID